Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6941270 | 0.77 | GBA1 (0.42) | POLBGBA1 | |
| SCHEMBL27775180 | 0.71 | MAOB (0.39) | — | |
| SCHEMBL15755799 | 0.69 | F2 (0.44) | POLBGBA1 | |
| SCHEMBL20561186 | 0.69 | POLB (0.44) | POLB | |
| Hydrochloric Acid SCHEMBL5696802 | 0.67 | SLC1A2 (0.43) | POLBGBA1 | |
| Hydrochloric Acid SCHEMBL6447076 | 0.67 | SLC1A2 (0.43) | POLBGBA1 | |
| SCHEMBL16241618 | 0.67 | HPGD (0.46) | GBA1 | |
| SCHEMBL28954933 | 0.67 | POLB (0.52) | POLBGBA1 | |
| SCHEMBL11474633 | 0.66 | GBA1 (0.53) | POLBGBA1 | |
| SCHEMBL10794275 | 0.66 | HSD11B1 (0.46) | POLBGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101321554-A | Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist | TTI ELLEBEAU INC (JP) | 2008-12-10 | — | — | CN | claimed |
| CN-1166640-C | Substituted 1,2,3,4,5, 6-hexahydro-2, 6-methano-3-benzazocin-10-ols, process for their preparation and their use as pharmaceutical compositions | ���ָ��Ӣ��ķ�������Ϲ�˾ | 2004-09-15 | — | — | CN | claimed |
| CN-1125053-C | Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R, 5S, 2'R')-3'-hydroxy-2-(2-methoxypropyl)-5,..... | BOEHRINGER INGELHEIM KG (DE) | 2003-10-22 | — | — | CN | claimed |
| CN-103405431-B | Opioid and opioid-like compounds and uses thereof | Taiwan J Pharmaceutical Co.,Ltd. (CN) | 2016-04-13 | — | — | CN | disclosed |
| CN-103405431-A | Opioid and opioid-like compounds and uses thereof | JENKEN BIOSCIENCES INC | 2013-11-27 | — | — | CN | disclosed |
| CN-103394090-A | Opioids for treatment of restless leg syndrome (RLS) | EURO CELTIQUE SA | 2013-11-20 | — | — | CN | disclosed |
| CN-1653050-B | Opioid and opioid-like compounds and uses thereof | JENKEN BIOSCIENCES INC | 2013-04-24 | — | — | CN | disclosed |
| CN-1984658-B | Opioids for the treatment of Chronic Obstructive Pulmonary Disease (COPD) | EURO CELTIQUE SA | 2012-04-18 | — | — | CN | disclosed |
| CN-101321554-A | Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist | TTI ELLEBEAU INC (JP) | 2008-12-10 | — | — | CN | disclosed |
| CN-1984658-A | Opioids for the treatment of the chronic obstructive pulmonary disease (COPD) | EURO CELTIQUE SA (LU) | 2007-06-20 | — | — | CN | disclosed |
| CN-1984659-A | Opioids for the treatment of Restless Leg Syndrome (RLS) | EURO CELTIQUE SA (LU) | 2007-06-20 | — | — | CN | disclosed |
| CN-1653050-A | Opioid and opioid-like compounds and uses thereof | JENKEN BIOSCIENCES INC (US) | 2005-08-10 | — | — | CN | disclosed |
| CN-1166640-C | Substituted 1,2,3,4,5, 6-hexahydro-2, 6-methano-3-benzazocin-10-ols, process for their preparation and their use as pharmaceutical compositions | ���ָ��Ӣ��ķ�������Ϲ�˾ | 2004-09-15 | — | — | CN | disclosed |
| WO-2003026635-A3 | IMPROVED METHOD OF TREATING THE SYNDROME OF TYPE 2 DIABETES IN HUMANS | CPD LLC (US) | 2004-04-01 | — | — | WO | disclosed |
| CN-1125053-C | Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R, 5S, 2'R')-3'-hydroxy-2-(2-methoxypropyl)-5,..... | BOEHRINGER INGELHEIM KG (DE) | 2003-10-22 | — | — | CN | disclosed |
| WO-2003026635-A2 | IMPROVED METHOD OF TREATING THE SYNDROME OF TYPE 2 DIABETES IN HUMANS | CPD, LLC (US) | 2003-04-03 | — | — | WO | disclosed |
| CN-1269790-A | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments | BOEHRINGER INGELHEIM PHARMA (DE) | 2000-10-11 | — | — | CN | disclosed |
| WO-1999003347-A1 | METHOD FOR TREATING NICOTINE ADDICTION | ALBANY MEDICAL COLLEGE (US) | 1999-01-28 | — | — | WO | disclosed |
| CN-1190959-A | New process for preparing pharmaceutically useful benzomorphane derivatives, particularly (-) - (1R,5S,2' ' -R) -3 ' -hydroxy-2- (2-methoxypropyl) -5, 9, 9-trimethyl-6, 7-benzomorphane intermediates, norbenzomorphane | BOEHRINGER INGELHEIM KG (DE) | 1998-08-19 | — | — | CN | disclosed |
| WO-1997042950-A1 | METHOD FOR TREATING COCAINE AND AMPHETAMINE DEPENDENCY | ALBANY MOLECULAR RESEARCH, INC. (US) | 1997-11-20 | — | — | WO | disclosed |